Tullow Oil (LON:TLW – Get Rating) had its price target dropped by equities research analysts at Canaccord Genuity Group from GBX 62 ($0.76) to GBX 54 ($0.66) in a research note issued to investors on Monday, MarketBeat.com reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective suggests a potential upside of 66.87% from the company’s previous close.
Several other research analysts have also recently issued reports on TLW. Barclays dropped their target price on shares of Tullow Oil from GBX 63 ($0.77) to GBX 62 ($0.76) and set an “overweight” rating on the stock in a report on Thursday, January 26th. JPMorgan Chase & Co. dropped their target price on shares of Tullow Oil from GBX 83 ($1.01) to GBX 56 ($0.68) and set an “overweight” rating on the stock in a report on Thursday, January 26th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of GBX 65 ($0.79).
Tullow Oil Stock Up 1.1 %
Shares of Tullow Oil stock opened at GBX 32.36 ($0.39) on Monday. The company has a debt-to-equity ratio of 457.18, a current ratio of 0.91 and a quick ratio of 0.63. Tullow Oil has a 1 year low of GBX 30.18 ($0.37) and a 1 year high of GBX 62.15 ($0.76). The firm’s 50-day moving average is GBX 35.33 and its two-hundred day moving average is GBX 40.31. The stock has a market cap of £465.98 million, a price-to-earnings ratio of 809.00, a PEG ratio of -0.19 and a beta of 2.12.
Tullow Oil Company Profile
Tullow Oil plc engages in the oil and gas exploration, development, and production activities primarily in Africa and South America. As of December 31, 2021, its portfolio comprised 30 licenses in 8 countries with 30 producing wells. The company was founded in 1985 and is headquartered in London, the United Kingdom.
Further Reading
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts Defend
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for Tullow Oil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tullow Oil and related companies with MarketBeat.com's FREE daily email newsletter.